Ads
related to: MRNA Stock
Search results
All In on Microsoft Stock: How AI Turned MSFT Into the Hottest Tech Play of 2024
InvestorPlace· 3 days agoMicrosoft (NASDAQ:MSFT) fell hard before it announced earnings on April 25, finishing the trading...
Earnings call: CureVac details strategic initiatives and clinical progress By Investing.com
Investing.com· 5 days agoCEO Alexander Zehnder emphasized the company's focus on streamlining operations, including the...
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
Zacks via Yahoo Finance· 7 days agoAnd, most ETFs are very transparent products that disclose...in the Healthcare sector - about 100%...
Is First Trust NASDAQ-100 Equal Weighted ETF (QQEW) a Strong ETF Right Now?
Zacks via Yahoo Finance· 7 days agoAnd, most ETFs are very transparent products that disclose...Discretionary and Healthcare round out...
REITs Q1 Earnings Begin On Solid Note
Benzinga via Yahoo Finance· 6 days agoGiven the recent talk about higher interest rates being a headwind for real estate investment trusts (REITs), investors might anticipate that...
The most jam-packed earnings week for the quarter lies ahead
Market Watch· 2 days ago, analysts are zeroed in on weaker demand in China, the iPhone upgrade cycle, Vision Pro demand and...
Cartesian Therapeutics (NASDAQ:RNAC) Price Target Raised to $54.00 at HC Wainwright
ETF DAILY NEWS· 7 days agoCartesian Therapeutics (NASDAQ:RNAC – Get Free Report) had its price target raised by research analysts at HC Wainwright from $2.00 to $54.00 in a research note issued to investors on Tuesday ...
Cartesian Therapeutics (NASDAQ:RNAC) Now Covered by Analysts at SVB Leerink
ETF DAILY NEWS· 7 days agoSVB Leerink began coverage on shares of Cartesian Therapeutics (NASDAQ:RNAC – Get Free Report) in a research note issued on Tuesday, Briefing.com reports. The brokerage set an “outperform” rating ...
Gaucho Group Holdings Receives Notice from Nasdaq Regarding Continued Listing Requirements
Digital Journal· 6 days agoDetails the Standards...
Altamira reports publication of positive results from NASAR clinical trial with Bentrio
Seeking Alpha· 6 days agoAltamira Therapeutics (CYTO) shares surge as positive results from the NASAR trial of their Bentrio nasal spray for allergic rhinitis are published.